Stroke Trial, Recruiting NCT05044208 Sponsor: Karl Landsteiner University of Health Sciences Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05044208
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who are able to give written agreement to take part in the study
  • People who have been clinically diagnosed with an ischemic stroke (a stroke caused by a blockage, not bleeding) or a transient ischemic attack (TIA, sometimes called a "mini-stroke"), confirmed by brain imaging such as a CT or MRI scan
  • People whose stroke is classified as "ESUS" (Embolic Stroke of Undetermined Source) — meaning the stroke was not a small, deep "lacunar" type, no significant narrowing of the brain's blood supply arteries was found, no major heart-related cause of the stroke was identified (such as a blood clot in the heart, a recent heart attack within 4 weeks, severely reduced heart pumping function, or certain heart valve problems), and no other specific cause was found (such as artery damage, drug use, or a blood-clotting disorder)
  • People whose TIA symptoms lasted less than 1 hour, and who meet all the same investigation criteria as stroke patients (brain imaging showing a lesion is optional for TIA)
  • All participants must have had a heart tracing (ECG), a heart ultrasound scan (echocardiogram), and at least 24 hours of heart rhythm monitoring before joining
  • People with a hole in the heart called a patent foramen ovale (PFO) are still eligible to join
  • People who have, or are planned to have, an implanted heart monitor or pacemaker are still eligible to join

Who may not be able to join:

  • People who have a history of atrial fibrillation (AF, an irregular heart rhythm), or in whom AF was detected on a heart tracing or heart rhythm monitoring before joining the study
  • People whose heart ultrasound (echocardiogram) was of too poor a quality to measure the key values needed for the study's scoring system (confirm with trial site)
  • People who wore the heart rhythm monitoring patch for less than 1 week in total (less than 168 hours combined), due to withdrawing from the study, the patch coming off, or a technical fault
  • People whose life expectancy is less than 1 month
  • People who are under legal guardianship or who are not mentally able to provide written informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Herbert Frank, Professor, Head of Internal Medicine Department, University Hospital Tulln

Phone: +4322729004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Karl Landsteiner University of Health Sciences
Registry
ClinicalTrials.gov
Start date
1 January 2021
Est. completion
1 November 2024

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Detection of former unrecognized atrial fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov